<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#comment> "2005 publication year MI:0886"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#comment> "Mol. Cell Proteomics (1535-9476) journal MI:0885"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#comment> "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer."^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#comment> "Benzinger A., Muster N., Koch HB., Yates JR., Hermeking H. author-list MI:0636"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-15778465> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-MINT-3974697> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#PXR-15778465> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_819797715610491844> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_634066270695245999> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_113162963749558578> .